Elevai Labs established two subsidiaries: Elevai Biosciences, Inc., and Elevai Skincare, Inc.Elevai Biosciences will focus on acquiring and developing biopharmaceutical technologies with initial focus.
Five international distribution agreements signed to dateCumulative contracted minimum purchase requirements of $4.9M in the first five yearsUp to five additional international distribution.
Company reports record annual revenues of $1.71 Million for 2023, up 123.5% over the previous year Company reports record Q4 2023 revenues of $698,591, up 403% from Q4 2022 NEWPORT BEACH, Calif.,.
Shares of NVIDIA Corporation (NASDAQ: NVDA) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for the first quarter.